Clinical Trials
21 trialsNCT03284866 2026-01-28
COVENANT
AIDS Malignancy Consortium
Phase 3 Completed
NCT04655144 2026-01-07
Dex-Fib
University of Miami
Phase 3 Completed
NCT04327063 2025-09-19
MIRs 04
Institut Curie
Phase 3 Completed
NCT02950155 2024-10-26
Rinomax
Karolinska Institutet
Phase 3 Completed
NCT05024253 2024-02-07
Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.
Children's Cancer Hospital Egypt 57357
Phase 3 Completed
NCT01685398 2023-09-21
Topical Timolol for Superficial Infantile Hemangioma
Mahidol University
Phase 3 Completed
NCT03027557 2021-05-25
DENOCINA
Aalborg University Hospital
Phase 3 Completed
NCT02655965 2021-01-27
DESIGN
Jules Bordet Institute
Phase 3 Completed
NCT04237090 2020-10-12
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
Phase 3 Completed
NCT02604225 2020-05-11
TRUSB
University of Sydney
Phase 3 Completed
NCT01806259 2020-04-07
KBCt
Université Catholique de Louvain
Phase 3 Completed
NCT01591746 2019-10-10
Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction
Mayo Clinic
Phase 3 Completed
NCT02408393 2019-07-10
MIRs03
Institut Curie
Phase 3 Completed
NCT02256228 2019-01-15
IPLA
Göteborg University
Phase 3 Completed
NCT02486198 2018-02-05
Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Completed
NCT01601314 2018-01-17
MAGNA
Fundacion Clinic per a la Recerca Biomédica
Phase 3 Completed
NCT01265810 2017-11-13
COMTT
Impaqtt Foundation
Phase 3 Completed
NCT03117335 2017-04-17
Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Phase 3 Completed
NCT01539317 2017-04-14
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
OHSU Knight Cancer Institute
Phase 3 Completed
NCT01836575 2013-04-22
PS2
Instituto Nacional de Cancer, Brazil
Phase 3 Completed
NCT00518895 2011-11-07
AGENDA
Genta Incorporated
Phase 3 Completed